NDC 0074-1825 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0074-1825
- Package NDCs from labels
- 0074-1825-30
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-1825-30 | Novocain | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 0074-1825-30 | Novocain | 100 in 1 CASE | INJECTION, SOLUTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hetastarch in Sodium Chloride | HETASTARCH | Hospira, Inc. | d64f961a-3e1f-4b04-cf83-604474af2775 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Aminocaproic Acid | AMINOCAPROIC ACID | Hospira, Inc. | 1c5bc1dd-e9ec-44c1-9281-67ad482315d9 | 2026-04-30 | Warnings, Adverse reactions | Hospira, Inc. |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Hospira, Inc. | 70057a53-ca29-4848-ab3d-5e691e2a14a3 | 2026-04-29 | Warnings, Adverse reactions | Hospira, Inc. |
| Potassium Acetate | POTASSIUM ACETATE | Hospira, Inc. | c58f8112-d587-493a-91b7-2b48c80bb7bf | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Potassium Acetate | POTASSIUM ACETATE | Hospira, Inc. | e9772b82-1e2b-4c4b-aa47-677491dbf73c | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | dc02a23b-3ff9-4441-aa91-8e9e629a7315 | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Potassium Acetate | POTASSIUM ACETATE | Hospira, Inc. | c7eabefd-2781-439b-b8f4-cb3ea25a4720 | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | e18ed1cb-7dd0-4001-bfda-17d1f4587fb8 | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | Sodium Chloride |
| Magnesium Sulfate | MAGNESIUM SULFATE | Hospira, Inc. | d4b5863a-efb9-4551-a9ad-2b06e8666d87 | 2026-04-23 | Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | 1d181906-f3ec-4222-1883-e61577a3122e | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | Hospira, Inc. |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | 3832ede8-d3fc-455d-ecab-3b77be5869f5 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| ROCURONIUM BROMIDE | ROCURONIUM BROMIDE | Hospira, Inc. | cccd40ca-5f08-4acb-8548-3cad558388bb | 2026-04-15 | Warnings, Adverse reactions | Hospira, Inc. |
| Midazolam | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | affecd4d-1f78-4bbe-5a8d-86849bbdc520 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| MANGANESE | MANGANESE CHLORIDE | Hospira, Inc. | 6e979070-5035-4076-e09c-b52466be3c68 | 2026-04-15 | Warnings, Adverse reactions | Hospira, Inc. |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | bb44c7e1-d911-4788-908f-09b7b271969b | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| TOBRAMYCIN | TOBRAMYCIN | Hospira, Inc. | c5a005b0-7b6f-4e30-df92-9a20b1ca66a1 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.